Aclaris Therapeutics Inc (ACRS) returns
Aclaris Therapeutics returns over 10 years
$1,000 invested in Aclaris Therapeutics ten years ago was worth $186.04 at the close on October 30, 2026, with dividends reinvested: an average return of -15.5% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -24.5% | — | $754.75 | -0.9% |
| 3 months | -25.4% | — | $746.24 | +2.1% |
| Year to date | +31.9% | — | $1,319 | +11.7% |
| 1 year | +59.4% | — | $1,594 | +12.4% |
| 3 years | -13.3% | -4.7% | $866.81 | +88.5% |
| 5 years | -77.1% | -25.5% | $228.82 | +76.0% |
| 10 years | -81.4% | -15.5% | $186.04 | +316.6% |
Aclaris Therapeutics return by calendar year
| Year | ACRS | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +31.9% | +11.7% | +20.2% |
| 2025 | +21.4% | +17.7% | +3.7% |
| 2024 | +136.2% | +24.9% | +111.3% |
| 2023 | -93.3% | +26.2% | -119.5% |
| 2022 | +8.3% | -18.2% | +26.5% |
| 2021 | +124.7% | +28.7% | +96.0% |
| 2020 | +242.3% | +18.4% | +224.0% |
| 2019 | -74.4% | +31.2% | -105.6% |
| 2018 | -70.0% | -4.6% | -65.5% |
| 2017 | -9.1% | +21.7% | -30.8% |
| 2016 | +0.7% | +12.0% | -11.3% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: ACRS financials
No forecast, no recommendation. This page describes Aclaris Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.